About Sirius Pharmaceuticals Private Limited
Data last updated:
Sirius Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1991PTC063523. Its GSTIN is 27AAECS6240D1ZK (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ajay Amerlal Melwani and Ayush Ajay Melwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 Sainara 21 North Avenue N. Linking Road Junction Santacruz (W), Mumbai, Maharashtra, India – 400054.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.16 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹5.22 Lakh (net margin 2.4%) and EBITDA of ₹7.74 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 10% over five years.
As per MCA filings, the company has satisfied charges of ₹3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website siriuspharma.com.
Company details
Contact details
Sirius Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is siriuspharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address301 Sainara 21 North Avenue N. Linking Road Junction Santacruz (W), Mumbai, Maharashtra, India – 400054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sirius Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sirius Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sirius Pharmaceuticals Private Limited, buy the company report.
Financials of Sirius Pharmaceuticals Private Limited
FY 2025 filings availableSirius Pharmaceuticals Private Limited reported revenue of ₹2.16 Cr (up 86% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 86% growth in the latest year. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sirius Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sirius Pharmaceuticals Private Limited
Sirius Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Amerlal Melwani | Director | 09 Oct 1991 | 35 Years 0 Months | Current |
| Ayush Ajay Melwani | Director | 07 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Sirius Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amstel Lifecare Private Limited | ₹2.16 Cr (FY 2024) | 37.0% | Thrissur, Kerala, India | |||
| Be-Line Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2025) | -9.0% | Thanjavur, Tamil Nadu, India | |||
| Sirius Pharmaceuticals Private Limitedthis company | ₹2.16 Cr (FY 2024) | ₹5.22 Lakh | 2.4% | 86.0% | Mumbai, Maharashtra, India | |
| Zenita Lifescience Private Limited | ₹2.16 Cr (FY 2025) | 13.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Sirius Pharmaceuticals Private Limited, buy the company report.
Auditor
Sirius Pharmaceuticals Private Limited is audited by N H GAJRIA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N H GAJRIA & CO | FY 2020 | 102928W |
Shareholding
The shareholding of Sirius Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sirius Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jan 2006 | 80003644 | Hdfc Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Sirius Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sirius Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sirius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sirius Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECS6240D1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sirius Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sirius Pharmaceuticals Private Limited has 5 board changes on record since 1991: 2 appointments and 3 cessations. The latest: Ayush Ajay Melwani ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Sirius Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 1991 (35+ years old) and is registered under CIN U24239MH1991PTC063523.
Sirius Pharmaceuticals has 2 current directors:
- Ajay Amerlal Melwani - Director
- Ayush Ajay Melwani - Director
The latest financial statements of Sirius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sirius Pharmaceuticals is 27AAECS6240D1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sirius Pharmaceuticals is U24239MH1991PTC063523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sirius Pharmaceuticals was incorporated on 09 October 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sirius Pharmaceuticals by revenue are Amstel Lifecare Private Limited, Be-Line Pharmaceuticals Private Limited, Zenita Lifescience Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ayush Ajay Melwani ceased to be Additional Director on 29 Sep 2018. Neeraj Maniyar ceased to be Director on 09 Sep 2018. Ayush Ajay Melwani was appointed as Director on 07 Sep 2018. Sirius Pharmaceuticals has 5 board changes on record in total.
Sirius Pharmaceuticals can be reached through the website siriuspharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sirius Pharmaceuticals is at 301 Sainara 21 North Avenue N. Linking Road Junction Santacruz W, Mumbai, Maharashtra, India – 400054.
Sirius Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
